Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Clinical trial NCT07322263 · RECRUITING

Trial details

NCT number: NCT07322263
Sponsor: Michael A. O'Donnell
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Cancer Non-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma Carcinoma in Situ (CIS)High-Grade Papillary Bladder Tumors BCG-Unresponsive Bladder Cancer Ta Stage Bladder Cancer T1 Stage Bladder Cancer BCG-Refractory Bladder Cancer High-Risk NMIBC Micropapillary Variant Urothelial Carcinoma (Favorable Subtype)

Start date: 2026-04-10
Primary completion: 2033-01-01
Enrollment: 174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.